Price Alert

Xilio Therapeutics Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

0.72

-0.00 (-0.53%)

At close: Sep 04, 2025, 3:56 PM

0.72

0.00%

Pre-market: Sep 05, 2025, 05:38 AM EDT

-0.53% (1D)

Bid	0.69
Market Cap	37.21M
Revenue (ttm)	15M
Net Income (ttm)	-56.22M
EPS (ttm)	-0.7
PE Ratio (ttm)	-1.03
Forward PE	-2.26
Analyst	Buy

Ask	0.74
Volume	184,587
Avg. Volume (20D)	427,206
Open	0.72
Previous Close	0.72
Day's Range	0.70 - 0.73
52-Week Range	0.61 - 1.70
Beta	-0.11

About XLO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XLO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for XLO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Xilio Therapeutics Inc. is scheduled to release its earnings on Nov 6, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-34.57%

Xilio Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

5 months ago

-6.2%

Xilio Therapeutics shares are trading lower. The company reported Q4 financial results.

News

3 weeks ago · zacks.com

Xilio Therapeutics, Inc. (XLO) Reports Q2 Loss, Misses Revenue Estimates

Xilio Therapeutics, Inc. (XLO) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.24 per share a year ago.